![Kelly Brady](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Kelly Brady
Directeur des opérations chez
SERES THERAPEUTICS, INC.
Fortune : 62 674 $ au 31/05/2026
Profil
Kelly M.
Brady is currently Chief Operating Officer & Executive Vice President at Seres Therapeutics, Inc. since 2026.
Former roles include Senior Director at Akebia Therapeutics, Inc. and Member-Operations Team at Osiris Therapeutics, Inc. Education includes graduate studies at The Johns Hopkins University and undergraduate studies at Lafayette College.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
SERES THERAPEUTICS INC 0,09 % | 18/05/2026 | 8 562 ( 0,09 % ) | 62 674 $ | 31/05/2026 |
Postes actifs de Kelly Brady
| Sociétés | Poste | Début |
|---|---|---|
| SERES THERAPEUTICS, INC. | Directeur des opérations | 02/03/2026 |
Anciens postes connus de Kelly Brady
| Sociétés | Poste | Fin |
|---|---|---|
| AKEBIA THERAPEUTICS, INC. | Corporate Officer/Principal | - |
| OSIRIS THERAPEUTICS, INC. | Corporate Officer/Principal | - |
Formation de Kelly Brady
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
19
Relations au 1er degré
5
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
Osiris Therapeutics, Inc.
 Osiris Therapeutics, Inc. BiotechnologyHealth Technology Researches and develops therapeutic products for the regeneration of human connective tissues | Health Technology |
The Johns Hopkins University
 The Johns Hopkins University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Lafayette College
 Lafayette College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Akebia Therapeutics, Inc.
 Akebia Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops drugs for kidney diseases | Health Technology |
Seres Therapeutics, Inc.
 Seres Therapeutics, Inc. BiotechnologyHealth Technology Develops novel treatments for diseases related to the human microbiome | Health Technology |
